Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-methyltyramine is a naturally occurring phenethylamine alkaloid and trace amine found in various plants. It is the N-methyl analog of tyramine and shares many pharmacological properties with it. In humans and plants, it is biosynthesized by the N-methylation of tyramine via specific methyltransferase enzymes. Pharmacologically, n-methyltyramine acts as a pressor agent (increases blood pressure), though its potency is much lower than epinephrine. It can enhance norepinephrine release from cardiac tissue and has stimulant properties that have led to its inclusion in some dietary supplements marketed for weight loss and athletic performance; however, there is no robust scientific evidence supporting these uses. Mechanistically, it acts as a competitive substrate for monoamine oxidase and may influence neurotransmitter metabolism[1][3][4][6]. Its use as a supplement ingredient has been subject to regulatory scrutiny due to safety concerns[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n-methyltyramine.